Facial Injectable Market Growth & Trends
The global facial injectable market size is expected to reach USD 35.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 9.1% from 2022 to 2030. The facial injectable is a substance that is used to reduce wrinkles and restore volume and fullness in the face. It is injected beneath the facial skin surface. Some commonly used facial injectable include hyaluronic acid, botulinum toxin type A, and polymer fillers.
Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.
In Asia Pacific, the market is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market. Companies such as Allergan are also expanding their presence in the country owing to the rise in the number of middle-class populations backed by increasing disposable income.
The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. However, the later months witnessed high demand for aesthetic consultations and procedures as patients were willing to undergo cosmetic treatments now more than ever due to high disposable income and desire to look appealing on zoom calls and online meetings.
Facial Injectable Market Report Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook